HYDERABAD/BENGALURU (Reuters) - Indian biopharmaceutical company Biocon reported a smaller-than-expected quarterly profit on Friday hurt by higher expenses. The company's consolidated net profit rose ...

BENGALURU/HYDERABAD May 8 (Reuters) - Indian biopharma firm Biocon's (BION.NS), opens new tab profit more than doubled in the fourth quarter, led by strong demand for its generics and biosimilar drugs ...

Biocon shares fell nearly 4% on Friday after the company posted its first-quarter (Q1) results for FY26, showing revenue growth but a sharp drop in profit. The company’s revenue from operations rose ...

HYDERABAD, Feb 8 (Reuters) - Indian biopharmaceutical company Biocon Ltd (BION.NS), opens new tab swung to a third-quarter profit on Thursday, boosted by its biosimilars business and the sale of some ...

Biocon posted its financial results for the quarter ending 30 June with its revenue from operations up 15% year-on-year at ₹3,942 crore, driven by gains in its biosimilars and CRDMO businesses. Its ...

Biocon in the second quarter of FY 23 has registered revenues to the tune of Rs 2,384 crore up by 23% as against the corresponding quarter which was at Rs 1,945 crore. However, its net profit has ...

Biocon on Tuesday reported a net profit of Rs 85 crore for the quarter ended September 30, 2025, compared to a loss of Rs 16 crore a year earlier, driven by strong biosimilar sales and improved ...

Biocon share price jumped over 4% to a fresh 52-week high on Thursday after reports stated that the company was evaluating an internal merger of its biosimilars arm, Biocon Biologics, with the parent ...

HYDERABAD (Reuters) - Biopharmaceutical company Biocon Ltd reported a more than six-fold rise in first-quarter profit on Thursday, boosted by a one-time gain from the sale of its Indian branded ...